ITOS
iTeos Therapeutics
ITOS
ITOS
Delisted
ITOS was delisted on the 28th of August, 2025.
135 hedge funds and large institutions have $262M invested in iTeos Therapeutics in 2024 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 50 increasing their positions, 44 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-14
Holders Change %
-9.4%
% of All Funds
1.8%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
27
Increased
50
Reduced
44
Closed
40
Calls
$5.88M
Puts
$21.2M
Net Calls
-$15.3M
Net Calls Change
-$38.3M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$17.9M |
| 2 |
JPMorgan Chase & Co
New York
|
$15.9M |
| 3 |
Citigroup
New York
|
$6.56M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$7.08M |
| 5 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
$3.92M |
